DEXTROSE INJECTION

The Defense Logistics Agency awarded a delivery order under the basic contract SPE2DX-25-D-8022 to Cardinal Health, Inc. (CAGE 00E55) for the procurement of Dextrose Injection (NSN 6505015015408, NDC 76329-3301-01), with a total contract value of $115.62. The order, issued on July 15, 2026, involves the delivery of two packages of the pharmaceutical product to the USS NITZE DDG 94 at FPO AE 09579, with FOB Destination terms placing transportation responsibility and associated costs on the contractor. Delivery must occur by the established date using the fastest traceable means, prohibiting parcel post, and all packaging and shipping documents must be clearly marked with the basic contract number, delivery order number, Transportation Control Number V231476195M20, and Receiving and Delivery Data 777. The contractor has certified as a small, small disadvantaged, and women-owned business, triggering compliance obligations under federal small business programs. Inspection and acceptance are performed by the government at the destination point, with payment processed electronically through the Defense Finance and Accounting Service, remitting to P.O. Box 182317, Columbus, OH 43218-2317 using payment code SL4701. The underlying contract structure is consistent with an IDIQ vehicle, though no options, special requirements, or explicit FAR/DFARS clauses were detailed in the available documentation. Contract administration is managed by Lisa Quinn, the contracting officer, with Michelle Pampel serving as a local administrator within DLA Troop Support’s Medical Supply Chain unit. No specific packaging standards, preservation controls, or bar-coding protocols were mandated beyond general traceability and DLA PROC NOTE C19/C20 references. The acquisition falls under NAICS 424210 for pharmaceutical and bulk drug merchant wholesalers.